Shanghai Junshi Biosciences Co Ltd Sustainability Reports

The company is an innovation-driven biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies. Its target areas primarily include oncology, autoimmune diseases, chronic metabolic diseases, neurologic diseases, and infectious diseases.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 300300L36FLCKN0WXW06

FIGI: BBG00MP13089

9 reports from 2018 to 2025

• Shanghai Junshi Biosciences Co Ltd 2025 Annual Report
• Shanghai Junshi Biosciences Co Ltd 2024 Annual Report
• Shanghai Junshi Biosciences Co Ltd 2024 Environmental, Social and Governance (ESG) Report
• Shanghai Junshi Biosciences Co Ltd 2023 Annual Report
• Shanghai Junshi Biosciences Co Ltd 2022 Annual Report